To the Editor,

Sepsis is the leading cause of death for critically ill patients. Septic patients develop T lymphocyte dysfunctions associated with increased mortality and nosocomial infections \[[@CR1]\]. Therefore, IL-7 has been recently evaluated in a clinical trial to reverse these alterations \[[@CR2]\]. IL-7 receptor (IL-7R) is composed of an IL-7-specific chain (CD127) and a common receptor γ-chain \[[@CR3]\]. IL-7R exists in a soluble form (sCD127) \[[@CR4]\], resulting from shedding from the cell surface or transcriptional regulation \[[@CR5], [@CR6]\]. Several transcripts missing the exon 6, coding for the transmembrane domain have been identified, such as IL7R3 \[[@CR4], [@CR6]\] and IL7R7 (Ensembl). We recently showed that plasmatic sCD127 concentration and whole blood IL7R3 transcript expression were decreased in septic shock \[[@CR7], [@CR8]\]. However, sCD127 protein and transcripts regulations in survivor and non-survivor patients differed, with higher sCD127 concentration and lower IL7R3 expression in non-survivors. Therefore, the regulation of soluble IL-7R in sepsis remains not fully understood.

In this study, we evaluated sCD127 release and corresponding transcripts IL7R3 and IL7R7 expressions in purified T cells from septic shock patients. After approval by local ethics committee, T cells were isolated from 32 septic shock patients (Table [1](#Tab1){ref-type="table"}) and 31 healthy volunteers (HV) (Additional file [1](#MOESM1){ref-type="media"}).Table 1Clinical characteristics of septic shock patientsParametersSeptic shock patients (*n* = 32)Sex, male26 (68%)Age, years70 \[62--76\]SAPS II score61 \[51--82\]SOFA score (*n* = 31)9 \[8--12\]Charlson co-morbidity score (*n* = 30) 03 (10%) 114 (47%)  \> 113 (43%)Mac Cabe score (*n* = 31) Non-fatal diseases21 (68%) Ultimately fatal diseases9 (29%) Rapidly fatal diseases1 (3%)Initial infection Abdominal infection16 (50%) Pneumopathy4 (12.5%) Urinary infection4 (12.5%) Other8 (25%)Type of admission Medical13 (41%) Emergency surgery18 (56%) Elective surgery1 (3%)Microbiological documentation Gram negative10 (31%) Gram positive7 (22%) Other1 (3%) Non-documented14 (44%)Mortality at D289 (28%)Lactate at D1 (mmol/L)2.8 \[1.7--5.6\]Lymphocytes at D3 (10^9^/L)1.05 \[0.6--1.35\]mHLA-DR at D3 (AB/C)8199 \[3076--12,171\]For clinical parameters, categorial data are presented as numbers of cases and percentages of the total population in brackets. Continuous data and biological parameters are presented as medians and interquartile ranges \[Q1-Q3\]. Simplified Acute Physiology Score II (SAPS II) and Mac Cabe score were calculated on admission. Sequential Organ Failure Assessment (SOFA) score was measured after 24 h of intensive care unit stay. mHLA-DR (AB/C): number of anti-HLA-DR antibodies bound per monocyte

Interestingly, the sCD127 release tended to be higher in patients' T cells supernatant compared to HV (Fig. [1](#Fig1){ref-type="fig"}). This contrasts with the decreased plasmatic sCD127 concentration in septic shock patients \[[@CR7]\], possibly impacted by lymphopenia. Both IL7R3 and IL7R7 transcripts expressions were decreased in septic shock patients' T cells (Fig. [2](#Fig2){ref-type="fig"}), as we previously observed in whole blood \[[@CR8]\]. While whole blood IL7R3 and IL7R7 expressions may be impacted by sepsis-induced lymphopenia, these transcripts are also intrinsically regulated in T cells.Fig. 1sCD127 protein release from purified T cells from septic shock patients. sCD127 release was quantified in supernatants of purified T cells of septic shock patients (D1, *n* = 9) in comparison with healthy volunteers (HV, *n* = 13) after 48 h of culture without any stimulation. Data are presented as Tukey boxplots. Mann-Whitney tests were used to compare values between septic shock patients and HV. \*\**p* \< 0.01, \*\*\**p* \< 0.001. See Additional file [1](#MOESM1){ref-type="media"} for detailsFig. 2IL7R mRNA transcripts expression in purified T cells from septic shock patients. Gene expressions of the IL7R3 and IL7R7 transcripts were measured using RT-qPCR from RNA from purified T cells from septic shock patients at D1 (*n* = 13), D3 (*n* = 21), and D7 (*n* = 7) in comparison with HV (*n* = 18). Data are presented as Tukey boxplots. Mann-Whitney tests were used to compare values between septic shock patients and HV. \*\**p* \< 0.01, \*\*\**p* \< 0.001. See Additional file [1](#MOESM1){ref-type="media"} for details

To delineate soluble IL-7R regulation in sepsis, we aimed to reproduce ex vivo its expression pattern observed in patients, by stimulating T cells from HV with IL-7 or TCR activation, known to regulate CD127 expression \[[@CR9]\]. sCD127 was spontaneously released from non-stimulated T cells (Fig. [3](#Fig3){ref-type="fig"}a). During IL-7 stimulation, sCD127 protein release and transcripts expression decreased. In contrast, TCR activation induced an opposite regulation of sCD127 and corresponding transcripts (Fig. [3](#Fig3){ref-type="fig"}b): sCD127 concentration increased, as previously described \[[@CR10]\], while IL7R7 and IL7R3 transcripts expressions decreased. This suggests that these transcripts are not the main source of sCD127 in this context, and that other mechanisms, such as shedding of membrane CD127, might occur. Overall, ex vivo TCR activation partly reproduced soluble IL-7R expression pattern observed in septic shock, suggesting that the initial T cell activation shown to occur in sepsis \[[@CR11], [@CR12]\] could participate to soluble IL-7R regulation, both at the transcriptional and protein levels.Fig. 3sCD127 release and transcripts expression upon ex vivo stimulation of healthy volunteers' purified T cells. **a** sCD127 protein release and **b** IL7R3 and IL7R7 mRNA transcripts expressions were measured in purified T cells from healthy volunteers (HV) stimulated ex vivo after the indicated time of incubation with IL-7 (*n* = 5, 10 ng/mL), anti-CD3/CD28 antibodies coated beads (*n* = 5, αCD3/28, 1:2 bead to cells ratio), or not stimulated (*n* = 10, NS). For each HV and each condition of stimulation, samples were proceeded in biological triplicates (culture wells) and technical duplicates (for ELISA only), summarized by the mean of the values for each individual. Data are presented as means and standard error of the mean. Mann-Whitney tests were used to compare values between non-stimulated and stimulated purified T cells from HV. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001. See Additional file [1](#MOESM1){ref-type="media"} for details

Altogether, we report here an intrinsic downregulation of IL-7R soluble transcripts in septic shock patients' T cells, independently of lymphopenia, in parallel with an increased sCD127 protein release. Ex vivo experiments in cells from HV suggest that initial T cell activation after sepsis might participate in this regulation, although this remains to be formally demonstrated.
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HV

:   Healthy volunteer

IL-7R

:   IL-7 receptor

sCD127

:   Soluble CD127

αCD3/28

:   Anti-CD3/CD28 antibodies coated beads
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